1000998-59-3,MFCD18251482
Catalog No.:AA0000U3

1000998-59-3 | Bms-687453

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$48.00   $33.00
- +
5mg
≥98%
in stock  
$205.00   $143.00
- +
10mg
≥98%
in stock  
$363.00   $254.00
- +
25mg
≥98%
in stock  
$790.00   $553.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0000U3
Chemical Name:
Bms-687453
CAS Number:
1000998-59-3
Molecular Formula:
C22H21ClN2O6
Molecular Weight:
444.8649
MDL Number:
MFCD18251482
SMILES:
COC(=O)N(Cc1cccc(c1)OCc1nc(oc1C)c1ccc(cc1)Cl)CC(=O)O
Properties
Computed Properties
 
Complexity:
601  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
9  
XLogP3:
3.8  

Literature

Title: Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation.

Journal: Bioorganic & medicinal chemistry letters 20100501

Title: Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).

Journal: Journal of medicinal chemistry 20100408

Title: Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20091001

Title: Li J, et al. Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). J Med Chem. 2010 Apr 8;53(7):2854-64.

Title: Mukherjee R, et al. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist. J Pharmacol Exp Ther. 2008 Dec;327(3):716-26.

Title: Vassallo JD, et al. Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin. Toxicol Sci. 2009 Oct;111(2):402-12.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1000998-59-3
Tags:1000998-59-3 Molecular Formula|1000998-59-3 MDL|1000998-59-3 SMILES|1000998-59-3 Bms-687453
Catalog No.: AA0000U3
1000998-59-3,MFCD18251482
1000998-59-3 | Bms-687453
Pack Size: 1mg
Purity: ≥98%
in stock
$48.00 $33.00
Pack Size: 5mg
Purity: ≥98%
in stock
$205.00 $143.00
Pack Size: 10mg
Purity: ≥98%
in stock
$363.00 $254.00
Pack Size: 25mg
Purity: ≥98%
in stock
$790.00 $553.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0000U3
Chemical Name: Bms-687453
CAS Number: 1000998-59-3
Molecular Formula: C22H21ClN2O6
Molecular Weight: 444.8649
MDL Number: MFCD18251482
SMILES: COC(=O)N(Cc1cccc(c1)OCc1nc(oc1C)c1ccc(cc1)Cl)CC(=O)O
Properties
Complexity: 601  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 7  
Hydrogen Bond Donor Count: 1  
Rotatable Bond Count: 9  
XLogP3: 3.8  
Literature fold

Title: Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation.

Journal: Bioorganic & medicinal chemistry letters20100501

Title: Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).

Journal: Journal of medicinal chemistry20100408

Title: Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20091001

Title: Li J, et al. Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453). J Med Chem. 2010 Apr 8;53(7):2854-64.

Title: Mukherjee R, et al. Novel peroxisome proliferator-activated receptor alpha agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist. J Pharmacol Exp Ther. 2008 Dec;327(3):716-26.

Title: Vassallo JD, et al. Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin. Toxicol Sci. 2009 Oct;111(2):402-12.

Building Blocks More >
100189-16-0
100189-16-0
5-(1-Hydroxyethyl)-2-methylpyridine
AA000148 | MFCD06637422
1003-09-4
1003-09-4
Thiophene, 2-bromo-
AA0001F2 | MFCD00005417
100366-74-3
100366-74-3
2-Iodo-6-(trifluoromethyl)pyridine
AA0001MX | MFCD11100178
10043-37-5
10043-37-5
2-Propen-1-one, 1-(1-piperidinyl)-
AA0001WB | MFCD00085224
1005342-46-0
1005342-46-0
LCL161
AA00026R | MFCD23160049
100701-49-3
100701-49-3
Propanedioic acid, 2-fluoro-, 1-ethyl ester
AA0002LC | MFCD20640383
1008106-86-2
1008106-86-2
2-Iodophenylboronic acid
AA0002V2 | MFCD09743934
1009303-56-3
1009303-56-3
4-Fluoro-3-(tetrazol-5-yl)phenylboronic acid
AA000357 | MFCD13176533
101-98-4
101-98-4
2-(Benzyl(methyl)amino)ethanol
AA0003DW | MFCD00002847
1011479-75-6
1011479-75-6
Diethyl 1-boc-azetidine-3-dicarboxylate
AA0003R9 | MFCD20126212
Submit
© 2017 AA BLOCKS, INC. All rights reserved.